Pull to refresh
Logo
Green Lumber expands recall after FDA finds hidden erectile drug in its own website sales

Green Lumber expands recall after FDA finds hidden erectile drug in its own website sales

Rule Changes

Seven years after regulators first flagged the supplement, the FDA says tadalafil turned up in capsules shipped directly from the company's California warehouse

Overview

Updated 34 minutes ago

Green Lumber Holdings is recalling a single lot of its male-enhancement supplement, Lot GL01, after the U.S. Food and Drug Administration (FDA) confirmed tadalafil in samples bought from the company's own website. Tadalafil is the active ingredient in Cialis, a prescription-only erectile dysfunction drug. The lot was shipped from Green Lumber's Costa Mesa, California warehouse between February 20 and August 31, 2026.

What makes this recall different from the company's earlier brushes with regulators is provenance. In 2025, Green Lumber blamed an employee for diverting packaging to counterfeiters. This lot came out of its own warehouse and was sold only directly to consumers. The FDA's public notice goes further than the recall, telling consumers not to use Green Lumber Natural Fuel For Men at all.

Why it matters

A supplement sold directly from a company's own warehouse contained a prescription heart-risk drug, so no packaging or lot exclusion can reassure a buyer.

Questions about this story

Free account needed to ask — your question is kept and asked for you right after sign-up. Answers are public.

No questions yet — be the first to ask.

Key Indicators

GL01
Lot under recall
Lot GL01, expiration 09/27, sold only through greenlumber.com.
11, 2026
Years since first FDA warning
FDA first notified the public about hidden tadalafil in Green Lumber in September 2019.
2
Lot codes the company says are unaffected
Green Lumber lists GL110725 (exp. 11/07/27) and GL02 (exp. 05/29) as current lots outside this recall.

Voices

Curated perspectives — historical figures and your fellow readers.

Sign up to generate historical perspectives on this story.

People Involved

Organizations Involved

Timeline

September 2019 November 2026

4 events Latest: 3 days ago
Tap a bar to jump to that date
  1. Lot GL01 recalled to consumer level

    Latest Recall

    Green Lumber recalled Lot GL01, saying the lot shipped only from its own warehouse.

  2. FDA reconfirms tadalafil in new samples

    Regulatory

    Tests on capsules bought from greenlumber.com came back positive for undeclared tadalafil.

  3. Company blames counterfeiters

    Statement

    Green Lumber said a former employee diverted real packaging to distribute adulterated capsules.

  4. FDA first flags hidden tadalafil

    Regulatory

    The FDA advised consumers not to use Green Lumber after lab tests found tadalafil in the product.

Scenarios

1

Recalled lot is destroyed, no injuries reported, case closes

Possible Resolves by Q1 2027

Discussed by: Company statement in the recall notice

Consumers return Lot GL01 for refunds, the company quarantines and destroys the stock in coordination with the FDA, and no adverse events surface. The company reports no adverse events to date. This path depends on the lot staying in the small population of direct buyers.

2

FDA widens warning as tests find tadalafil in other lots

Possible Resolves by Q2 2027

Discussed by: FDA public notification, which already advises against any use of the product

The FDA's notice tells consumers to avoid the product entirely, not just Lot GL01. Further testing of the two lots the company calls unaffected, or of future batches, could confirm tadalafil again and push the recall broader.

3

Company has to explain how tadalafil entered its own supply chain

Uncertain Resolves by May 31, 2027

Discussed by: Medical Daily and consumer-health outlets

The 2025 explanation blamed a rogue employee and counterfeiters. This lot came from the company's own warehouse, and the notice does not explain how the drug got there. Retailer or regulatory pressure for an explanation could follow, though no such action has been announced.

Historical Context

2 moments from history that rhyme with this story — and how they unfolded.

2000s-present

FDA hidden-drug supplement warnings (ongoing since 2000s)

The FDA's medication health fraud program routinely tests supplements marketed for sexual enhancement and finds prescription drugs such as sildenafil and tadalafil that are not on the label. Products are typically sold online and pulled only after testing.

Then

Companies issue recalls or simply rebrand; the products often stay on sale under new labels.

Now

The FDA has repeatedly warned that it cannot test every product, leaving consumers to judge risk themselves.

Why this matters now

Green Lumber's seven-year record of repeat positive tests, with each round ending in a recall or a blame-shifting notice, follows this pattern.

August 2025

Green Lumber counterfeit alert (2025)

After the FDA again found tadalafil in products labeled Green Lumber, the company said an internal investigation found an employee had diverted real packaging and customer information to distribute adulterated capsules. The employee was terminated. The company listed a specific authentic lot number and said tadalafil was not in any genuine product.

Then

The company positioned the problem as counterfeiting rather than its own manufacturing.

Now

That explanation does not fit the 2026 finding, when the tainted samples were bought from the company's own site and the recalled lot shipped from its warehouse.

Why this matters now

The 2026 recall removes the counterfeiting explanation for at least one lot and shifts the question to the company's own distribution.

Sources

(6)